GE HealthCare Technologies Inc., a global leader in healthcare technologies, exhibits a robust performance in the medical industry. With a diversified segment structure and strong analyst ratings, the company shows promising growth potential. However, the debt to equity ratio suggests a point for cautious consideration.
The company demonstrates a solid fundamental performance, reflected by an overall score of 4. Key strength areas include return on equity and assets.
Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 3 | |
Price to Book | 2 |
Review the changes in fundamental scores over recent periods to identify trends.
Date | Overall | Discounted Cash Flow | Return on Equity | Return on Assets | Debt to Equity | Price to Earnings | Price to Book |
---|---|---|---|---|---|---|---|
2025-10-10 | 4 | 4 | 5 | 5 | 1 | 3 | 2 |
Current | 0 | 4 | 5 | 5 | 1 | 3 | 2 |
Analyst price targets indicate potential value recognition, with a consensus leaning towards growth.
High | Low | Median | Consensus |
---|---|---|---|
$95 | $73 | $74 | $80.67 |
Overall positive sentiment from analysts with strong buy and buy recommendations dominating.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 0 | |
Buy | 11 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
GE HealthCare Technologies Inc. presents a compelling investment case with strong fundamentals and positive analyst sentiment. The robust return metrics highlight the company's competitive advantage. However, the debt levels may warrant careful monitoring in the future. The market consensus points towards potential growth, as reflected in the analyst price targets. Overall, GEHC appears to be a promising investment in the healthcare sector.